TruBridge (TBRG) to Release Earnings on Wednesday

TruBridge (NASDAQ:TBRG - Get Free Report) is projected to release its Q1 2025 earnings data before the market opens on Wednesday, May 7th. Analysts expect TruBridge to post earnings of $0.37 per share and revenue of $86.21 million for the quarter. TruBridge has set its FY 2025 guidance at EPS and its Q2 2025 guidance at EPS.

TruBridge (NASDAQ:TBRG - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.29 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by ($0.08). TruBridge had a negative net margin of 17.72% and a positive return on equity of 1.78%. On average, analysts expect TruBridge to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

TruBridge Trading Up 0.2 %

NASDAQ:TBRG traded up $0.04 during trading hours on Wednesday, hitting $25.50. The company had a trading volume of 153,285 shares, compared to its average volume of 128,885. The company has a 50-day moving average of $26.51 and a 200 day moving average of $22.32. The company has a current ratio of 1.80, a quick ratio of 1.78 and a debt-to-equity ratio of 1.00. The company has a market cap of $381.20 million, a P/E ratio of -6.23, a P/E/G ratio of 5.38 and a beta of 0.65. TruBridge has a 1 year low of $7.98 and a 1 year high of $32.00.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Cantor Fitzgerald increased their target price on shares of TruBridge from $20.00 to $29.00 and gave the stock an "overweight" rating in a research note on Tuesday, March 11th. Stephens reiterated an "equal weight" rating and issued a $28.00 target price on shares of TruBridge in a report on Thursday, April 10th.

Insiders Place Their Bets

In other news, CEO Christopher L. Fowler sold 5,100 shares of the firm's stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $27.02, for a total value of $137,802.00. Following the completion of the sale, the chief executive officer now directly owns 142,939 shares of the company's stock, valued at $3,862,211.78. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Pinetree Capital Ltd. purchased 74,981 shares of the stock in a transaction dated Thursday, February 13th. The shares were bought at an average cost of $27.61 per share, for a total transaction of $2,070,225.41. Following the completion of the purchase, the insider now owns 693,981 shares in the company, valued at approximately $19,160,815.41. This trade represents a 12.11 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 116,728 shares of company stock valued at $3,239,879. Insiders own 10.70% of the company's stock.

TruBridge Company Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.